SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Lindberger M)
 

Search: WFRF:(Lindberger M) > Gabapentin versus v...

  • Lindberger, M (author)

Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.

  • Article/chapterEnglish2000

Publisher, publication year, extent ...

  • Wiley,2000

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/250983
  • https://gup.ub.gu.se/publication/250983URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:1948290URI
  • https://doi.org/10.1111/j.1528-1157.2000.tb04607.xDOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Our objective was to compare the efficacy and safety of gabapentin and vigabatrin as first-line add-on treatment in patients with partial epilepsy.This was a multicenter, double-blind, randomized dose titration study. After baseline assessment and randomization, the dose could be increased if seizures persisted and reduced if side effects occurred. Health-related quality of life was assessed at baseline and at the end of the study. By a protocol amendment post hoc, all randomized patients were offered a standardized perimetry examination at the end of the study. Improvement rate was the proportion of patients with a reduction of seizure frequency of at least 50% during an 8-week period without any adverse events causing withdrawal.One hundred two patients were randomized and analyzed on an intent-to-treat basis. The improvement rate was 48% in the gabapentin group and 56% in the vigabatrin group. The improvement rate, when per protocol criteria were fulfilled, was 57% in the gabapentin group and 59% in the vigabatrin group. The proportion of seizure-free patients was 31% in the gabapentin group and 39% in the vigabatrin group. There was no difference in quality-of-life scores between the groups. Perimetry after termination of the study on 64 patients showed abnormal results in 3 of 32 patients in the vigabatrin group.Approximately one third of the patients in both groups became seizure-free. Although no major differences were seen in terms of the improvement rate between the groups, equivalence between the two drugs was not found.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Alenius, M (author)
  • Frisén, Lars,1939Gothenburg University,Göteborgs universitet,Institutionen för klinisk neurovetenskap, Sektionen för oftalmologi,Institute of Clinical Neurosciences, Section of Ophtalmology(Swepub:gu)xfrisl (author)
  • Johannessen, S I (author)
  • Larsson, S (author)
  • Malmgren, K (author)
  • Tomson, TKarolinska Institutet (author)
  • Göteborgs universitetInstitutionen för klinisk neurovetenskap, Sektionen för oftalmologi (creator_code:org_t)

Related titles

  • In:Epilepsia: Wiley41:10, s. 1289-950013-95801528-1167

Internet link

Find in a library

  • Epilepsia (Search for host publication in LIBRIS)

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view